Pediatric Patient Blood Management Programs: Not Just Transfusing Little Adults

Transfusion Medicine Reviews

Volumn 30, Issue 4, 2016, Pages 235-241

  Goel, Ruchika ^a   Cushing, Melissa M ^a   Tobian, Aaron A R ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood conservation; Children; Patient blood management; Pediatrics; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRINOGEN CONCENTRATE; HEMOGLOBIN; TRANEXAMIC ACID;

BLEEDING; BLOOD CONSERVATION; BLOOD DONOR; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; HEALTH PROGRAM; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE; MEDICAL DECISION MAKING; OPERATIVE BLOOD LOSS; PATIENT MONITORING; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POINT OF CARE TESTING; POPULATION RESEARCH; POSTOPERATIVE CARE; PRACTICE GUIDELINE; RESOURCE MANAGEMENT; REVIEW; TREATMENT INDICATION; ADOLESCENT; ANEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL TRIAL (TOPIC); HEMATOLOGY; INFANT; METHODOLOGY; NEWBORN; PRESCHOOL CHILD; PROCEDURES; STANDARDS; THROMBOCYTE TRANSFUSION; TRENDS;

ADOLESCENT; ANEMIA; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; HEMATOLOGY; HEMOGLOBINS; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; PERIOPERATIVE CARE; PLATELET TRANSFUSION; RESEARCH DESIGN;

EID: 84992758957     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2016.07.004     Document Type: Review

References (95)

1. [1] Demaret, P, et al. Red blood cell transfusion in critically ill children (CME). Transfusion 54:2 (2014), 365–375.
2. [2] Laverdiere, C, et al. Survey on transfusion practices of pediatric intensivists. Pediatr Crit Care Med 3:4 (2002), 335–340.
3. [3] Nahum, E, Ben-Ari, J, Schonfeld, T, Blood transfusion policy among European pediatric intensive care physicians. J Intensive Care Med 19:1 (2004), 38–43.
4. [4] New, HV, et al. Red blood cell transfusion practice in children: current status and areas for improvement? A study of the use of red blood cell transfusions in children and infants. Transfusion 54:1 (2014), 119–127.
5. [5] Federowicz, I, et al. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 36:1 (1996), 21–28.
6. [6] Popovsky, MA, Audet, AM, Andrzejewski, C Jr., Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 12:2 (1996), 87–89.
7. [7] Clifford, L, et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 122:1 (2015), 21–28.
8. [8] DeBaun, MR, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med 371:8 (2014), 699–710.
9. [9] Toy, P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 119:7 (2012), 1757–1767.
10. [10] Zou, S, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 50:7 (2010), 1495–1504.
11. [11] Stramer, SL, et al. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?. Transfusion 53 (2013), 2449–2458.
12. [12] Stainsby, D, et al. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol 141:1 (2008), 73–79.
13. [13] Lavoie, J, Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 21:1 (2011), 14–24.
14. [14] Sullivan, GH, Five “rights” equal 0 errors. RN 54:6 (1991), 65–66, 68.
15. [15] Kluwer, W, Nursing drug handbook. 32nd ed., 2012, Lippincott Williams & Wilkins, Philadelphia, PA.
16. [16] AABB, AABB white papers: building a better patient blood management program identifying tools, solving problems and promoting patient safety. 2015.
17. [17] Markowitz, MA, Waters, JH, Ness, PM, Patient blood management: a primary theme in transfusion medicine. Transfusion, 54, 2014, 2587.
18. [18] Bateman, ST, et al. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med 178:1 (2008), 26–33.
19. [19] Secher, EL, Stensballe, J, Afshari, A, Transfusion in critically ill children: an ongoing dilemma. Acta Anaesthesiol Scand 57:6 (2013), 684–691.
20. [20] Roseff, SD, Luban, NL, Manno, CS, Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42:11 (2002), 1398–1413.
21. [21] Hebert, PC, et al. Physiologic aspects of anemia. Crit Care Clin 20:2 (2004), 187–212.
22. [22] Dhabangi, A, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 314:23 (2015), 2514–2523.
23. [23] Carson, JL, Carless, PA, Hebert, PC, Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 4, 2012, CD002042.
24. [24] Lacroix, J, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356:16 (2007), 1609–1619.
25. [25] Adams, ES, A critical appraisal of “transfusion strategies for patients in pediatric intensive care units” by Lacroix J, Hebert PC, Hutchison, et al (N Engl J Med 2007; 356:1609-1619). Pediatr Crit Care Med 10:3 (2009), 393–396.
26. [26] Karam, O, et al. Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med 12:5 (2011), 512–518.
27. [27] Rouette, J, et al. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: a randomized clinical trial. Ann Surg 251:3 (2010), 421–427.
28. [28] Lacroix, J, Tucci, M, Du Pont-Thibodeau, G, Red blood cell transfusion decision making in critically ill children. Curr Opin Pediatr 27:3 (2015), 286–291.
29. [29] Tyrrell, CT, Bateman, ST, Critically ill children: to transfuse or not to transfuse packed red blood cells, that is the question. Pediatr Crit Care Med 13:2 (2012), 204–209.
30. [30] Lackritz, EM, et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 340:8818 (1992), 524–528.
31. [31] Lackritz, EM, et al. Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS 11:12 (1997), 1487–1494.
32. [32] English, M, et al. Blood transfusion for severe anaemia in children in a Kenyan hospital. Lancet 359:9305 (2002), 494–495.
33. [33] Carson, JL, Patel, MS, Red blood cell transfusion thresholds: can we go even lower?. Transfusion 54 (2014), 2593–2594.
34. [34] Stey, AM, et al. Variation in intraoperative and postoperative red blood cell transfusion in pediatric surgery. Transfusion 56:3 (2016), 666–672.
35. [35] Klaus, SA, et al. Hemoglobin thresholds for transfusion in pediatric patients at a large academic health center. Transfusion 55:12 (2015), 2890–2897.
36. [36] Goodnough, LT, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 101:6 (2005), 1858–1861.
37. [37] Lachance, K, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 45:6 (2011), 764–770.
38. [38] Goddard, AF, et al. Guidelines for the management of iron deficiency anaemia. Gut 60:10 (2011), 1309–1316.
39. [39] Munoz, M, et al. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 94:3 (2008), 172–183.
40. [40] Munoz, M, et al. On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus 10:1 (2012), 8–22.
41. [41] Beris, P, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 100:5 (2008), 599–604.
42. [42] Testa, U, Erythropoietic stimulating agents. Expert Opin Emerg Drugs 15:1 (2010), 119–138.
43. [43] Rodd, HD, Blankenstein, R, Iron-deficiency anaemia in young children requiring dental extractions under general anaesthesia. Int J Paediatr Dent 5:1 (1995), 9–14.
44. [44] Heaton, JM, et al. An assessment of the incidence of iron deficiency in paediatric otolaryngology inpatients. J Laryngol Otol 105:12 (1991), 1021–1024.
45. [45] Ootaki, Y, et al. The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery. Heart Surg Forum 10:2 (2007), E115–E119.
46. [46] Smith, SN, Milov, DE, Use of erythropoietin in Jehovah's Witness children following acute gastrointestinal blood loss. J Fla Med Assoc 80:2 (1993), 103–105.
47. [47] Akingbola, OA, et al. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 22:3 (1994), 524–528.
48. [48] KDIGO, Clinical practice guideline for anemia in chronic kidney disease., 2(4), 2012.
49. [49] Hibino, N, et al. Preoperative autologous blood donation for cardiac surgery in children. Asian Cardiovasc Thorac Ann 16:1 (2008), 21–24.
50. [50] Solves, P, et al. Results of a preoperative autologous blood donation program for patients undergoing elective major spine surgery. Transfus Apher Sci 49:2 (2013), 345–348.
51. [51] Ikegami, S, et al. Efficacy of erythropoietin-beta injections during autologous blood donation before spinal deformity surgery in children and teenagers. Spine (Phila Pa 1976) 40:21 (2015), E1144–E1149.
52. [52] Tasaki, T, Ohto, H, Nineteen years of experience with autotransfusion for elective surgery in children: more troublesome than we expected. Transfusion 47:8 (2007), 1503–1509.
53. [53] Lauder, GR, Pre-operative predeposit autologous donation in children presenting for elective surgery: a review. Transfus Med 17:2 (2007), 75–82.
54. [54] Weiskopf, RB, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279:3 (1998), 217–221.
55. [55] Leung, JM, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 93:4 (2000), 1004–1010.
56. [56] Weiskopf, RB, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 92:6 (2000), 1646–1652.
57. [57] Bhananker, SM, et al. Anesthesia-related cardiac arrest in children: update from the pediatric perioperative cardiac arrest registry. Anesth Analg 105:2 (2007), 344–350.
58. [58] Faraoni, D, Goobie, SM, The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. Anesth Analg 118:3 (2014), 628–636.
59. [59] Fontana, JL, et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 80:2 (1995), 219–225.
60. [60] Hans, P, et al. Evaluation of acute normovolemic hemodilution for surgical repair of craniosynostosis. J Neurosurg Anesthesiol 12:1 (2000), 33–36.
61. [61] Joseph, SA Jr., et al. Blood conservation techniques in spinal deformity surgery: a retrospective review of patients refusing blood transfusion. Spine (Phila Pa 1976) 33:21 (2008), 2310–2315.
62. [62] Cholette, JM, et al. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatr Crit Care Med 14:2 (2013), 137–147.
63. [63] Bowen, RE, et al. Efficacy of intraoperative cell salvage systems in pediatric idiopathic scoliosis patients undergoing posterior spinal fusion with segmental spinal instrumentation. Spine (Phila Pa 1976) 35:2 (2010), 246–251.
64. [64] Fearon, JA, Reducing allogenic blood transfusions during pediatric cranial vault surgical procedures: a prospective analysis of blood recycling. Plast Reconstr Surg 113:4 (2004), 1126–1130.
65. [65] Samnaliev, M, et al. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth 23:11 (2013), 1027–1034.
66. [66] Golab, HD, et al. Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial. Eur J Cardiothorac Surg 34:2 (2008), 354–359.
67. [67] Baumann, C, et al. Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices. Paediatr Anaesth 25:3 (2015), 258–264.
68. [68] Seyfried, T, et al. Processing of small volumes in blood salvage devices. Transfusion 54 (2014), 2775–2781.
69. [69] Goobie, SM, et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114:4 (2011), 862–871.
70. [70] Schouten, ES, et al. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 10:2 (2009), 182–190.
71. [71] Tzortzopoulou, A, et al. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev, 3, 2008, CD006883.
72. [72] Nishijima, DK, et al. Tranexamic acid use in United States children's hospitals. J Emerg Med 50:6 (2016), 868–874.
73. [73] Beno, S, et al. Tranexamic acid in pediatric trauma: why not?. Crit Care, 18(4), 2014, 313.
74. [74] Eckert, MJ, et al. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma Acute Care Surg 77:6 (2014), 852–858 [discussion 858].
75. [75] Carling, MS, et al. Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in scoliosis surgery. Spine (Phila Pa 1976) 36:7 (2011), 549–555.
76. [76] Haas, T, et al. Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: a prospective randomised controlled trial. Br J Anaesth 115:2 (2015), 234–243.
77. [77] Guay, J, de Moerloose, P, Lasne, D, Minimizing perioperative blood loss and transfusions in children. Can J Anaesth 53:6 Suppl. (2006), S59–S67.
78. [78] Stricker, PA, et al. Reconstituted blood reduces blood donor exposures in children undergoing craniofacial reconstruction surgery. Paediatr Anaesth 21:1 (2011), 54–61.
79. [79] Manno, CS, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 77:5 (1991), 930–936.
80. [80] Jobes, DR, Sesok-Pizzini, D, Friedman, D, Reduced transfusion requirement with use of fresh whole blood in pediatric cardiac surgical procedures. Ann Thorac Surg 99:5 (2015), 1706–1711.
81. [81] Mazine, A, et al. Blood transfusions after pediatric cardiac operations: a North American multicenter prospective study. Ann Thorac Surg 100:2 (2015), 671–677.
82. [82] Schindler, E, et al. Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery. Eur J Cardiothorac Surg 39:4 (2011), 495–499.
83. [83] Lu, J, et al. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. Int J Clin Exp Pathol 8:7 (2015), 7978–7987.
84. [84] Henry, DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 3, 2011, CD001886.
85. [85] Henry, DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 4, 2007, CD001886.
86. [86] Kwak, JG, et al. Multiple approaches to minimize transfusions for pediatric patients in open-heart surgery. Pediatr Cardiol 37:1 (2016), 44–49.
87. [87] Naguib, AN, et al. A single-center strategy to minimize blood transfusion in neonates and children undergoing cardiac surgery. Paediatr Anaesth 25:5 (2015), 477–486.
88. [88] Kane, LC, et al. Thromboelastography-does it impact blood component transfusion in pediatric heart surgery?. J Surg Res 200:1 (2016), 21–27.
89. [89] Faraoni, D, et al. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study. Paediatr Anaesth 25:6 (2015), 573–579.
90. [90] Romlin, BS, et al. Earlier detection of coagulopathy with thromboelastometry during pediatric cardiac surgery: a prospective observational study. Paediatr Anaesth 23:3 (2013), 222–227.
91. [91] Goobie, SM, Haas, T, Perioperative bleeding management in pediatric patients. Curr Opin Anaesthesiol 29:3 (2016), 352–358.
92. [92] Esper, SA, et al. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg 118:4 (2014), 731–743.
93. [93] Northrop, MS, et al. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life. Pediatr Crit Care Med 16:1 (2015), 66–74.
94. [94] Voelker, MT, et al. Restrictive transfusion practice during extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome. Artif Organs 39:4 (2015), 374–378.
95. [95] Agerstrand, CL, et al. Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome. Ann Thorac Surg 99:2 (2015), 590–595.